Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged withAnticoagulant

Xarelto is under fire, if you follow the allegations in the over 550 lawsuits filed to date. Xarelto is one of the newer oral anticoagulant medications that has been approved by the FDA. The federal Xarelto personal injury and product liability claims are centralized before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.

Xarelto is one of the newer oral anticoagulant medications that has been approved by the FDA.

As a Dallas Xarelto Bleeding Death attorney and Texas medical doctor, I would like to update my readers about the ongoing status of the Xarelto litigation. Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen.

Danny Julien recently filed a claim in the U.S. District Court for the Eastern District of Louisiana, on behalf of his father, Tommy Julien, who died as a result of uncontrollable bleeding.

According to the personal injury and death lawsuit, Julien suffered from atrial fibrillation and used Xarelto to prevent strokes from the atrial fibrillation. Julien developed severe internal bleeding while on Xarelto, which eventually led to his death.

According to court documents and a review of the inventory of filed lawsuits against the makers of Xarelto, the litigation appears to be gathering steam and increasing in breadth and depth. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted consolidated pretrial proceedings for all federal Xarelto cases filed against Bayer and Johnson & Johnson’s Janssen subsidiary over the new-generation blood thinner.

The Xarelto personal injury and product liability claims are centralized before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.Bayer and Johnson & Johnson is now exposed to at least 220 bleeding cases in the federal multi-district litigation (MDL), with more on the way.

The U.S. Judicial Panel on Multidistrict Litigation announced consolidation and centralization of all nationwide Xarelto lawsuits filed in federal courts before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.

Over 50 Federal Xarelto Lawsuits

Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to at least 50 product liability lawsuits over their new-generation anticoagulant. These personal injury and wrongful death claims are pending in 24 different federal courts.

Today, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments to consolidate all federal Xarelto lawsuits before one judge, in one centralized U.S. District Court.

It is widely anticipated that the U.S. JPML will establish centralized proceedings for coordinated discovery and a series of bellwether trials.

Patients who took Xarelto accuse the drug manufacturers of downplaying Xarelto’s bleeding risks and asked that the cases be sent to U.S District Judge David Herndon in East St. Louis, Illinois. An order maybe granted before the upcoming holiday season.

A Vermont man who suffered deadly brain bleed has filed a wrongful death lawsuit. The family alleges that the death was caused by side effects of Xarelto, a new generation anticoagulant. Xarelto, has recently come under fire from its irreversible bleeding side effects and is the subject of many similar lawsuits.

Thomas C. Dunkley’s daughter Ruth McGowen, filed a claim against Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary on July 25, in the U.S. District Court for the District of Vermont.

According to the Xarelto allegations, Dunkley was prescribed the blood thinner anticoagulant in July 2012, for treatment of atrial fibrillation to reduce the risk of a embolic stroke.

Germany based Boehringer Ingelheim, the manufacturer of the anticoagulant medication Pradaxa has agreed to pay $650 million to settle Pradaxa injury lawsuits. There are 4,000 lawsuits on file by folks who allege that the company failed to warn about the risk of severe and deadly bleeding problems with the anticoagulant drug use.

Pradaxa, has been linked to more than 500 patient deaths. The settlement comes about week after the drugmaker said a new analysis of a company-funded study used to win approval of the Pradaxa found 22 serious bleeding events that weren’t included in the original report.

If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at the addresses above.

In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violators. All 3rd party material posted on this website is copyright the respective owners/authors. DallasFortWorthInjuryLawyer.com / ShezadMalik.com makes no claim of copyright on such material.